Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Privacy Policy  
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Equine /     
 
Screening test for GBE1 developed
The gene responsible for glycogen branching enzyme deficiency (GBED) has been discovered recently. About one-fourth of foals born to carriers of the faulty make-up is killed by this defect. Now breeders can screen for GBE1 so carriers do not pass it to offspring!


Stephanie Valberg, DVM, PhD, led the research team at the University of Minnesota (UM) in identifying the GBE1 gene, which encodes the glycogen branching enzyme (GBE) involved in glycogen synthesis.

Veterinary medicine researchers have been working to discover the cause of early death in foals for the past five years, but GBE1 has been difficult to pinpoint.

GBED occurs when horses that carry the recessive gene breed with another carrier, says Dr. Jim Mickelson, UM researcher and professor of veterinary bioscience. Quarterhorses and similar breeds run the greatest risk of carrying the defective GBE1 gene, but mixed breeds also run the risk of passing on the trait to their offspring.

The foal`s deficiency is camouflaged by symptoms that resemble other equine neonatal diseases. Breeders often determine that foals` deaths are caused naturally instead of considering genetics as a probable cause, Mickelson says.

Foals that are born weak can die very soon after birth, or they can be nursed into health in the hospital, Valberg says.

`The foals seem to get stronger for a while and then die very suddenly,` Valberg adds. `Other foals have spent much more time in the hospital and have progressively gotten weaker to the point where they can no longer stand up.`

Weak foals lacked an enzyme required to form glycogen, the glycogen branching enzyme. Without glucose to metabolize energy, the foals were unable to survive more than two months.

`If owners of the majority of Quarterhorses have a planned breeding program to avoid carriers, the defective gene will eventually die out,` says Valberg.

The discovery of the gene led to a new test that can screen horses for the trait before they are bred.

For $35 per horse, stallions and mares can be tested, sparing emotional and economic loss by a foal carrying the defective trait.

Blood samples, as well as mane or tail samples with intact roots, can be used for the test, Valberg says.

Ten percent of all Quarterhorses in the United States are carriers of the defective gene, Mickelson says. Approximately 50,000 horses a year could be affected by the gene, Mickelson adds.

`More than 300 tests have already been conducted,` Valberg says.

The study was funded through the American Quarter Horse Association and the University of Minnesota Equine Center with funds provided by the Minnesota Racing Commission.

Source: Jessica Tremayne (2004): Researchers at UM find gene that causes death. In: DVM Newsmagazine Nov 1, 2004





Tell a friend   |   Print version   |   Send this article

EQUINE

Presumed Neuroglycopenia following Severe Hypoglycemia in Horsesmembers
Neuroglycopenia refers to a shortage of glucose in the brain resulting in neuronal dysfunction and death if left untreated. Presumed neuroglycopenia has not been described in horses. Thus, the objective of this retrospective study was to report neurological signs in horses with presumed neuroglycopenia as the result of severe hypoglycemia.

  • E321G MYH1 mutation and nonexertional rhabdomyolysis in Quarter Horsesmembers
  • Novel therapeutic approach for mares with suspected uterine tubal blockagemembers
  • Unusual cause of unilateral facial swelling in a coltmembers
  • Novel topical therapy of equine sarcoidsmembers
  • Conventional radiography versus CT to diagnose osteomyelitis in foalsmembers
  • Novel surgical treatment of recurrent laryngeal neuropathy in horses members
  • Standing repair of a fracture of the third metatarsal bone of a Hunt Thoroughbred mare members
  • Unusual cause of bilateral blindness in a young Quarter Horsemembers
  • Advanced imaging of an incomplete fracture of Os metacarpale III in a young Warmbloodmembers
  • Equine external beam radiation therapymembers
  • Insulin dysregulation in horses with SIRSmembers
  • The farrier role in supporting horse owners to prevent laminitismembers


  • [ Home ] [ About ] [ Contact / Request ] [ Privacy Policy ]

    Copyright © 2001-2018 VetContact GmbH
    All rights reserved